,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1195,1,2,,48416024,3380,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
1,1580,1,1,,8150136,3380,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
2,1581,1,1,,8150136,3380,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
3,1582,1,1,,8150136,3380,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
4,1583,1,1,,8150136,3380,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
5,1584,1,1,,8150136,3380,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
6,1585,1,1,,8150136,3380,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
7,1586,1,1,,8150136,3380,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
8,1587,1,1,,8150136,3380,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
9,1588,1,1,,8150136,3380,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
10,1589,1,1,,8150136,3380,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
11,1590,1,1,,8150136,3380,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
12,1593,1,1,,8150136,3380,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
13,1594,1,1,,8150136,3380,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
14,1595,1,1,,8150136,3380,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
15,1596,1,1,,8150136,3380,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
16,1597,1,1,,8150136,3380,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
17,1598,1,1,,8150136,3380,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
18,1599,1,1,,8150136,3380,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
19,1600,1,1,,8150136,3380,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
20,1601,1,1,,8150136,3380,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
21,1602,1,1,,8150136,3380,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
22,1603,1,1,,8150136,3380,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
23,1604,1,1,,8150136,3380,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
24,1605,1,1,,8150136,3380,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
25,1606,1,1,,8150136,3380,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
26,1607,1,1,,8150136,3380,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
27,1608,1,1,,8150136,3380,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
28,1609,1,1,,8150136,3380,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
29,1610,1,1,,8150136,3380,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
30,1612,1,1,,8150136,3380,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
31,1613,1,1,,8150136,3380,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
32,1614,1,1,,8150136,3380,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
33,1616,1,1,,8150136,3380,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
34,13304,3,3,,103174540,3380,Unspecified,,,,,-Log C was determined by performing the electroshock minimum test,Other,7381845.0,
35,13305,3,3,,103174540,3380,Unspecified,,,,,-Log C was determined by performing the foot shock test,Other,7381845.0,
36,13306,3,3,,103174540,3380,Unspecified,,,,,-Log C was determined by performing the incl screen test,Other,7381845.0,
37,13307,3,3,,103174540,3380,Unspecified,,,,,-Log C was determined by performing the maximum electroshock test,Other,7381845.0,
38,13308,3,3,,103174540,3380,Unspecified,,,,,-Log C was determined by performing the pentylenetetrazole test,Other,7381845.0,
39,22293,4,4,,103174540,3380,Unspecified,,,,,Delta logD (logD6.5 - logD7.4),Other,10891117.0,
40,26304,4,4,,103174540,3380,Unspecified,,,,,Partition coefficient (logD6.5),Other,10891117.0,
41,29360,4,3,,103174540,3380,Inconclusive,,,,,Ionization constant (pKa),Other,10891117.0,
42,29811,4,3,,103174540,3380,Unspecified,,,,,Oral bioavailability in human,Other,10891117.0,
43,40817,9,5,,103174540,3380,Active,120758.0,289606.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
44,40817,9,5,,103174540,3380,Active,120761.0,24947.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
45,40817,9,5,,103174540,3380,Active,120763.0,140675.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
46,40817,9,5,,103174540,3380,Active,120764.0,29707.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
47,40817,9,5,,103174540,3380,Active,120769.0,25450.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
48,40817,9,5,,103174540,3380,Active,120782.0,140674.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
49,40817,9,5,,103174540,3380,Active,120788.0,29709.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
50,40817,9,5,,103174540,3380,Active,120790.0,79211.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
51,40817,9,5,,103174540,3380,Active,232127.0,29708.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
52,40817,9,5,,103174540,3380,Active,544363.0,29689.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
53,40817,9,5,,103174540,3380,Active,3023821.0,81658.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
54,40817,9,5,,103174540,3380,Active,13959374.0,65191.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
55,40817,9,5,,103174540,3380,Active,51317298.0,29705.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
56,40817,9,5,,103174540,3380,Active,52000955.0,24922.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
57,40817,9,5,,103174540,3380,Active,52000957.0,25451.0,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
58,40817,9,5,,103174540,3380,Active,81902501.0,,0.0017,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,Confirmatory,2885419.0,
59,40826,9,5,,103174540,3380,Active,120758.0,289606.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
60,40826,9,5,,103174540,3380,Active,120761.0,24947.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
61,40826,9,5,,103174540,3380,Active,120763.0,140675.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
62,40826,9,5,,103174540,3380,Active,120764.0,29707.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
63,40826,9,5,,103174540,3380,Active,120769.0,25450.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
64,40826,9,5,,103174540,3380,Active,120782.0,140674.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
65,40826,9,5,,103174540,3380,Active,120788.0,29709.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
66,40826,9,5,,103174540,3380,Active,120790.0,79211.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
67,40826,9,5,,103174540,3380,Active,232127.0,29708.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
68,40826,9,5,,103174540,3380,Active,544363.0,29689.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
69,40826,9,5,,103174540,3380,Active,3023821.0,81658.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
70,40826,9,5,,103174540,3380,Active,13959374.0,65191.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
71,40826,9,5,,103174540,3380,Active,51317298.0,29705.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
72,40826,9,5,,103174540,3380,Active,52000955.0,24922.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
73,40826,9,5,,103174540,3380,Active,52000957.0,25451.0,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
74,40826,9,5,,103174540,3380,Active,81902501.0,,0.0017,IC50,Inhibition of [3H]diazepam binding to GABA-A benzodiazepine receptor of rat brain,Confirmatory,2848124.0,
75,40827,7,5,,103174540,3380,Active,120758.0,289606.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
76,40827,7,5,,103174540,3380,Active,120761.0,24947.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
77,40827,7,5,,103174540,3380,Active,120763.0,140675.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
78,40827,7,5,,103174540,3380,Active,120764.0,29707.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
79,40827,7,5,,103174540,3380,Active,120769.0,25450.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
80,40827,7,5,,103174540,3380,Active,120782.0,140674.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
81,40827,7,5,,103174540,3380,Active,120788.0,29709.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
82,40827,7,5,,103174540,3380,Active,120790.0,79211.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
83,40827,7,5,,103174540,3380,Active,232127.0,29708.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
84,40827,7,5,,103174540,3380,Active,544363.0,29689.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
85,40827,7,5,,103174540,3380,Active,3023821.0,81658.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
86,40827,7,5,,103174540,3380,Active,13959374.0,65191.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
87,40827,7,5,,103174540,3380,Active,51317298.0,29705.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
88,40827,7,5,,103174540,3380,Active,52000955.0,24922.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
89,40827,7,5,,103174540,3380,Active,52000957.0,25451.0,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
90,40827,7,5,,103174540,3380,Active,81902501.0,,0.008,IC50,Displacement of [3H]beta-CCE from GABA-A benzodiazepine receptor of rat cerebral cortex membranes,Confirmatory,3037081.0,
91,40987,5,4,,103174540,3380,Unspecified,,,3801890.0,IC50,Binding affinity of compound towards Benzodiazepine receptor in a competition assay,Confirmatory,8978853.0,
92,40995,5,4,,103174540,3380,Unspecified,,,3801890.0,IC50,Binding affinity towards benzodiazepine/GABA A receptor.,Confirmatory,7861419.0,
93,42335,7,5,,103174540,3380,Active,120758.0,289606.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
94,42335,7,5,,103174540,3380,Active,120761.0,24947.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
95,42335,7,5,,103174540,3380,Active,120763.0,140675.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
96,42335,7,5,,103174540,3380,Active,120764.0,29707.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
97,42335,7,5,,103174540,3380,Active,120769.0,25450.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
98,42335,7,5,,103174540,3380,Active,120782.0,140674.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
99,42335,7,5,,103174540,3380,Active,120788.0,29709.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
100,42335,7,5,,103174540,3380,Active,120790.0,79211.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
101,42335,7,5,,103174540,3380,Active,232127.0,29708.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
102,42335,7,5,,103174540,3380,Active,544363.0,29689.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
103,42335,7,5,,103174540,3380,Active,3023821.0,81658.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
104,42335,7,5,,103174540,3380,Active,13959374.0,65191.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
105,42335,7,5,,103174540,3380,Active,51317298.0,29705.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
106,42335,7,5,,103174540,3380,Active,52000955.0,24922.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
107,42335,7,5,,103174540,3380,Active,52000957.0,25451.0,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
108,42335,7,5,,103174540,3380,Active,81902501.0,,0.0015,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,Confirmatory,1846920.0,
109,52275,10,5,,103174540,3380,Unspecified,2495000.0,100719593.0,100.0,IC50,Half-maximal inhibition of [125I]CCK-33 binding to guinea pig brain(cortex) cholecystokinin receptor,Confirmatory,2885419.0,
110,52280,9,1,,103174540,3380,Unspecified,,,100.0,IC50,Half-maximal inhibition of [125I]-CCK-8(+) binding to cholecystokinin receptor from guinea pig brain tissue,Confirmatory,2848124.0,
111,52410,9,2,,103174540,3380,Unspecified,,,100.0,IC50,Half-maximal inhibition of [125I]-CCK-33 binding to rat pancreas cholecystokinin receptor,Confirmatory,2885419.0,
112,52413,9,2,,103174540,3380,Unspecified,,,100.0,IC50,Half-maximal inhibition of [125I]CCK-33 binding to cholecystokinin A receptor from rat pancreatic tissue,Confirmatory,2848124.0,
113,71266,7,2,,103174540,3380,Unspecified,,,2.0,Ki,Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-6-beta-3-gamma-2,Confirmatory,10633039.0,
114,71267,7,1,,103174540,3380,Unspecified,,,2.0,Ki,Binding affinity measured using LtK- cell membranes expressing Gamma-aminobutyric acid A receptor alpha-6-beta-3-gamma-2,Confirmatory,9651158.0,
115,72448,3,10,,103174540,3380,Unspecified,27808653.0,2554.0,,,Ability to affect GABA-induced chloride current in Xenopus oocytes transiently expressing human GABA-A alpha-1-beta-2-gamma-2 receptors using two-electrode voltage-clamp electrophysiology at test concentration of 1 uM,Other,10890169.0,
116,72448,3,10,,103174540,3380,Unspecified,116242488.0,2566.0,,,Ability to affect GABA-induced chloride current in Xenopus oocytes transiently expressing human GABA-A alpha-1-beta-2-gamma-2 receptors using two-electrode voltage-clamp electrophysiology at test concentration of 1 uM,Other,10890169.0,
117,72448,3,10,,103174540,3380,Unspecified,292495010.0,2561.0,,,Ability to affect GABA-induced chloride current in Xenopus oocytes transiently expressing human GABA-A alpha-1-beta-2-gamma-2 receptors using two-electrode voltage-clamp electrophysiology at test concentration of 1 uM,Other,10890169.0,
118,72640,7,2,,103174540,3380,Active,,,0.0039,Ki,Binding affinity evaluated by ability to displace [3H]Ro-151788 from recombinant human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-2 expressed in L(tk-)cells,Confirmatory,10890169.0,
119,72927,7,2,,103174540,3380,Active,,,0.0022,Ki,Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-1-beta-3-gamma-2,Confirmatory,10633039.0,
120,73077,7,2,,103174540,3380,Active,,,0.0011,Ki,Binding affinity evaluated by ability to displace [3H]-Ro-15-1788 from recombinant human Gamma-aminobutyric acid A receptor alpha-2-beta-3-gamma-2 expressed in L(tk-)cells,Confirmatory,10890169.0,
121,73089,8,2,,103174540,3380,Active,,,0.0025,Ki,Binding affinity to human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-2-beta-3-gamma-2,Confirmatory,10633039.0,
122,73232,7,2,,103174540,3380,Active,,,0.0059,Ki,Binding affinity evaluated by ability to displace [3H]Ro-151788 from recombinant human Gamma-aminobutyric acid A receptor alpha-3-beta-3-gamma-2 expressed in L(tk-)cells,Confirmatory,10890169.0,
123,73244,8,2,,103174540,3380,Active,,,0.0045,Ki,Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-3-beta-3-gamma-2,Confirmatory,10633039.0,
124,73523,7,2,,103174540,3380,Active,,,0.0021,Ki,Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-5-beta-3-gamma-2,Confirmatory,10633039.0,
125,73529,7,1,,103174540,3380,Active,,,0.0021,Ki,Binding affinity measured using LtK- cell membranes expressing Gamma-aminobutyric acid A receptor alpha-5-beta-3-gamma-2,Confirmatory,9651158.0,
126,139100,3,3,,103174540,3380,Unspecified,,,,,Logarithm of effective dose evaluated using the foot-shock test in mice,Other,6876077.0,
127,219791,7,1,,103174540,3380,Active,,,0.0022,Ki,Binding affinity measured using LtK- cell membranes expressing GABA alpha-1-beta-3-gamma-2 receptor,Confirmatory,9651158.0,
128,219938,7,1,,103174540,3380,Active,,,0.0025,Ki,Binding affinity measured using LtK- cell membranes expressing GABA alpha-2-beta-3-gamma-2 receptor,Confirmatory,9651158.0,
129,219953,7,1,,103174540,3380,Active,,,0.0045,Ki,Binding affinity measured using LtK- cell membranes expressing GABA alpha-3-beta-3-gamma-2 receptor,Confirmatory,9651158.0,
130,226385,7,5,,103174540,3380,Active,120758.0,289606.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
131,226385,7,5,,103174540,3380,Active,120761.0,24947.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
132,226385,7,5,,103174540,3380,Active,120763.0,140675.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
133,226385,7,5,,103174540,3380,Active,120764.0,29707.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
134,226385,7,5,,103174540,3380,Active,120769.0,25450.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
135,226385,7,5,,103174540,3380,Active,120782.0,140674.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
136,226385,7,5,,103174540,3380,Active,120788.0,29709.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
137,226385,7,5,,103174540,3380,Active,120790.0,79211.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
138,226385,7,5,,103174540,3380,Active,232127.0,29708.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
139,226385,7,5,,103174540,3380,Active,544363.0,29689.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
140,226385,7,5,,103174540,3380,Active,3023821.0,81658.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
141,226385,7,5,,103174540,3380,Active,13959374.0,65191.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
142,226385,7,5,,103174540,3380,Active,51317298.0,29705.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
143,226385,7,5,,103174540,3380,Active,52000955.0,24922.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
144,226385,7,5,,103174540,3380,Active,52000957.0,25451.0,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
145,226385,7,5,,103174540,3380,Active,81902501.0,,0.003,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane,Confirmatory,3037081.0,
146,227697,4,3,,103174540,3380,Unspecified,,,,,Compound was evaluated for the Anti-fighting behavior.,Other,2202830.0,
147,227698,4,3,,103174540,3380,Unspecified,,,,,Evaluation for the Anti-pentylenetetrazole effect.,Other,2202830.0,
148,228469,4,3,,103174540,3380,Unspecified,,,,,Evaluation of inclined screen test.,Other,2202830.0,
149,229422,4,5,,103174540,3380,Unspecified,,,,,"Selectivity of binding to pancreatic CCK and brain benzodiazepine receptors, ratio of IC50",Other,2885419.0,
150,232605,4,3,,103174540,3380,Unspecified,,,,,Ratio of IC50 CCK(pancreas)/ IC50BZD (brain),Other,2848124.0,
151,232720,3,5,,103174540,3380,Unspecified,,,,,Selectivity ratio of alpha1 beta-3 gamma2 GABA A / BzR and alpha5 beta-3 gamma2 GABA A / BzR,Other,10633039.0,
152,243422,3,10,,103174540,3380,Unspecified,116241312.0,1576.0,,,log (1/Km) value for human liver microsome cytochrome P450 3A4,Other,15990295.0,
153,343089,7,3,,103174540,3380,Active,,,0.0045,Kd,Binding affinity to GABAA alpha-1-beta-2-gamma-2 receptor,Confirmatory,18537233.0,
154,343090,7,3,,103174540,3380,Active,,,,Ki,Binding affinity to GABAA alpha-5-beta-2-gamma-2 receptor,Confirmatory,18537233.0,
155,365608,4,3,,103174540,3380,Active,,,,IC50,Displacement of [3H]flumazenil from CBR in bovine cortical membrane,Confirmatory,18637672.0,
156,365609,4,3,,103174540,3380,Active,,,0.0065,Ki,Displacement of [3H]flumazenil from CBR in human cortical membrane,Confirmatory,18637672.0,
157,365610,3,3,,103174540,3380,Unspecified,,,,,Ratio of Ki for bovine CBR in absence of GABA to Ki for bovine CBR in presence of 50 uM GABA,Other,18637672.0,
158,365611,3,3,,103174540,3380,Unspecified,,,,,Ratio of Ki for human CBR in absence of GABA to Ki for human CBR in presence of 50 uM GABA,Other,18637672.0,
159,385592,5,1,,103174540,3380,Unspecified,27808653.0,2554.0,,,Activity at human GABAA alpha-1-beta-2-gamma-2L receptor in HEK293 cells expressing as-PKCepsilon assessed as evoked current response by whole cell patch clamp method,Other,17875639.0,
160,385593,3,5,,103174540,3380,Unspecified,,,,,"Activity at human GABAA alpha1beta2 S410A-gamma-2-LS327A,S343A receptor in HEK293 cells expressing as-PKCepsilon assessed as evoked current response by whole cell patch clamp method",Other,17875639.0,
161,385594,3,5,,103174540,3380,Unspecified,27808653.0,2554.0,,,"Activity at human GABAA alpha-1-beta-2-gamma-2 LS327A,S343A receptor in HEK293 cells expressing as-PKCepsilon assessed as evoked current response by whole cell patch clamp method",Other,17875639.0,
162,385594,3,5,,103174540,3380,Unspecified,116242488.0,2566.0,,,"Activity at human GABAA alpha-1-beta-2-gamma-2 LS327A,S343A receptor in HEK293 cells expressing as-PKCepsilon assessed as evoked current response by whole cell patch clamp method",Other,17875639.0,
163,385594,3,5,,103174540,3380,Unspecified,292495010.0,2561.0,,,"Activity at human GABAA alpha-1-beta-2-gamma-2 LS327A,S343A receptor in HEK293 cells expressing as-PKCepsilon assessed as evoked current response by whole cell patch clamp method",Other,17875639.0,
164,385595,3,5,,103174540,3380,Unspecified,27808653.0,2554.0,,,Activity at human GABAA alpha-1-beta-2-gamma-2 LS327A receptor in HEK293 cells expressing as-PKCepsilon assessed as evoked current response by whole cell patch clamp method,Other,17875639.0,
165,385595,3,5,,103174540,3380,Unspecified,116242488.0,2566.0,,,Activity at human GABAA alpha-1-beta-2-gamma-2 LS327A receptor in HEK293 cells expressing as-PKCepsilon assessed as evoked current response by whole cell patch clamp method,Other,17875639.0,
166,385595,3,5,,103174540,3380,Unspecified,292495010.0,2561.0,,,Activity at human GABAA alpha-1-beta-2-gamma-2 LS327A receptor in HEK293 cells expressing as-PKCepsilon assessed as evoked current response by whole cell patch clamp method,Other,17875639.0,
167,385596,3,5,,103174540,3380,Unspecified,,,,,Activity at human GABAA alpha-1-beta-2-S410A-gamma-2L receptor in HEK293 cells expressing as-PKCepsilon assessed as evoked current response by whole cell patch clamp method,Other,17875639.0,
168,385600,3,10,,103174540,3380,Unspecified,27808653.0,2554.0,,,Activity of human GABA alpha-1-beta-2-gamma-2L receptor in HEK293 cells assessed as activation of current at 300 nM,Other,17875639.0,
169,385601,3,4,,103174540,3380,Unspecified,,,,,Activity of human GABA alpha-1-beta-2-gamma-2 LS327A mutant in HEK293 cells assessed as activation of current at 300 nM,Other,17875639.0,
170,385602,3,10,,103174540,3380,Unspecified,27808653.0,2554.0,,,Activity of human GABA alpha-1-beta-2-gamma-2Lreceptor in HEK293 cells assessed as inactivation of current at 300 nM,Other,17875639.0,
171,385603,3,4,,103174540,3380,Unspecified,,,,,Activity of human GABA alpha-1-beta-2-gamma-2 LS327A mutant in HEK293 cells assessed as inactivation of current at 300 nM,Other,17875639.0,
172,385604,5,1,,103174540,3380,Active,27808653.0,2554.0,0.0014,EC50,Activity at human GABAA alpha-1-beta-2-gamma-2S327 receptor in HEK293 cells expressing as-PKCepsilon cells assessed as evoked current response by whole cell patch clamp method,Confirmatory,17875639.0,
173,385604,5,1,,103174540,3380,Active,116242488.0,2566.0,0.0014,EC50,Activity at human GABAA alpha-1-beta-2-gamma-2S327 receptor in HEK293 cells expressing as-PKCepsilon cells assessed as evoked current response by whole cell patch clamp method,Confirmatory,17875639.0,
174,385604,5,1,,103174540,3380,Active,292495010.0,2561.0,0.0014,EC50,Activity at human GABAA alpha-1-beta-2-gamma-2S327 receptor in HEK293 cells expressing as-PKCepsilon cells assessed as evoked current response by whole cell patch clamp method,Confirmatory,17875639.0,
175,492967,1,2,,99302069,3380,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
176,493162,1,2,,99302069,3380,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
177,539464,4,2,,103174540,3380,Unspecified,,,,,Solubility of the compound in 0.1 M phosphate buffer at 600 uM at pH 7.4 after 24 hrs by LC/MS/MS analysis,Other,21055935.0,
178,540209,4,3,,103174540,3380,Unspecified,,,,,Volume of distribution at steady state in human after iv administration,Other,18426954.0,
179,540210,4,3,,103174540,3380,Unspecified,,,,,Clearance in human after iv administration,Other,18426954.0,
180,540211,2,5,,103174540,3380,Unspecified,,,,,Fraction unbound in human after iv administration,Other,18426954.0,
181,540212,4,3,,103174540,3380,Unspecified,,,,,Mean residence time in human after iv administration,Other,18426954.0,
182,540213,4,3,,103174540,3380,Unspecified,,,,,Half life in human after iv administration,Other,18426954.0,
183,588211,2,3,,103174540,3380,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
184,588212,2,3,,103174540,3380,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
185,588213,2,3,,103174540,3380,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
186,624647,3,4,,103174540,3380,Unspecified,,,190.0,Ki,Inhibition of AZT glucuronidation by human UGT enzymes from liver microsomes,Confirmatory,15781124.0,
187,672795,1,3,,103174540,3380,Unspecified,,,,,Displacement of [3H]flumazenil from central benzodiazepine receptor in rat cerebral cortex membranes at 10 uM after 90 mins by competitive binding assay,Other,22489952.0,
188,701021,1,2,,103174540,3380,Active,,,0.00517,Ki,Displacement of [3H]flumazenil from central benzodiazepine receptor in bovine cortical membrane after 90 mins by beta liquid scintillation counting,Confirmatory,21751815.0,
189,701022,1,2,,103174540,3380,Active,,,0.0065,Ki,Displacement of [3H]flumazenil from central benzodiazepine receptor in human cortical membrane after 90 mins by beta liquid scintillation counting,Confirmatory,21751815.0,
190,701023,1,2,,103174540,3380,Unspecified,,,,,Ratio of Ki for central benzodiazepine receptor in bovine cortical membrane to Ki for central benzodiazepine receptor in bovine cortical membrane in presence of 50 uM GABA,Other,21751815.0,
191,701024,1,2,,103174540,3380,Unspecified,,,,,Ratio of Ki for central benzodiazepine receptor in human cortical membrane to Ki for central benzodiazepine receptor in human cortical membrane in presence of 50 uM GABA,Other,21751815.0,
192,701026,1,2,,103174540,3380,Active,,,,,Agonist activity at central benzodiazepine receptor in Sprague-Dawley rat cerebrocortical synaptoneurosomes assessed as increase in GABA-induced [36]chloride ion flow after 10 seconds by beta liquid scintillation counting,Other,21751815.0,
193,1097336,1,3,,103174540,3380,Unspecified,,,,,Drug level in Homo sapiens (human) whole blood assessed as retention time by UPLC-TOF-MS analysis,Other,,
194,1150161,1,1,,103174540,3380,Unspecified,,,,,Sedative activity in mouse,Other,926122.0,
195,1150162,1,1,,103174540,3380,Unspecified,,,,,Muscle relaxant activity in mouse,Other,926122.0,
196,1150163,1,1,,103174540,3380,Unspecified,,,,,Taming activity in mouse assessed as suppression of electrical current-induced aggressive behavior by foot-shock test,Other,926122.0,
197,1150164,1,1,,103174540,3380,Unspecified,,,,,Anticonvulsion activity in mouse assessed as protection against pentylenetetrazole-induced convulsion,Other,926122.0,
198,1150165,1,1,,103174540,3380,Unspecified,,,,,Muscle relaxant activity in cat suspended by scruff of neck assessed as relaxation of body and hind legs,Other,926122.0,
199,1159387,1,2,,103174540,3380,Unspecified,,,,,"ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured  by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5",Other,,
200,1159396,1,2,,103174540,3380,Unspecified,,,,,"ASTRAZENECA: Intrinsic clearance measured in human hepatocytes following incubation at 37C. Experimental range <3 to >150 microL/min/1E6 cells. Rapid Commun. Mass Spectrom. 2010, 24, 1730-1736.",Other,,
201,1224923,1,1,,103174540,3380,Active,,,,,Summary of drugs withdrawn.,Other,,
202,1259407,1,1,,363903237,3380,Active,,,,,CCRIS mutagenicity studies,Other,,
